Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.

Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, Tominaga T.

Neurosurgery. 2014 Feb;74(2):163-70; discussion 170. doi: 10.1227/NEU.0000000000000238.

PMID:
24176958
3.

Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.

Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T.

Cerebrovasc Dis. 2012;33(5):436-45. doi: 10.1159/000336765. Epub 2012 Mar 28.

PMID:
22456617
4.

Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.

Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T.

Surg Neurol. 2009 Apr;71(4):442-7. doi: 10.1016/j.surneu.2008.02.031. Epub 2008 Jun 2.

PMID:
18514264
5.

Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease.

Hwang JW, Yang HM, Lee H, Lee HK, Jeon YT, Kim JE, Lim YJ, Park HP.

Br J Anaesth. 2013 May;110(5):773-9. doi: 10.1093/bja/aes470. Epub 2012 Dec 28.

PMID:
23274781
6.

Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.

Sakata H, Fujimura M, Mugikura S, Sato K, Tominaga T.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):e179-84. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.050. Epub 2015 May 6.

PMID:
25957910
7.
8.

Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.

Fujimura M, Kaneta T, Shimizu H, Tominaga T.

Childs Nerv Syst. 2007 Oct;23(10):1195-8. Epub 2007 May 8.

PMID:
17486352
9.
12.

Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?

Mukerji N, Cook DJ, Steinberg GK.

J Neurosurg. 2015 Jan;122(1):90-4. doi: 10.3171/2014.8.JNS132413.

PMID:
25343178
13.

Operative wound-related complications after cranial revascularization surgeries.

Takanari K, Araki Y, Okamoto S, Sato H, Yagi S, Toriyama K, Yokoyama K, Murotani K, Matsui S, Wakabayashi T, Kamei Y.

J Neurosurg. 2015 Nov;123(5):1145-50. doi: 10.3171/2014.12.JNS132602. Epub 2015 Jul 3.

PMID:
26140494
14.

Reversible occlusion of donor vessel caused by mouth opening after superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya patients.

Katsuta T, Abe H, Miki K, Inoue T.

J Neurosurg. 2015 Sep;123(3):670-5. doi: 10.3171/2014.10.JNS141805. Epub 2015 Apr 24.

PMID:
25909570
16.

Indocyanine green videoangiography for assessment of postoperative hyperperfusion in moyamoya disease.

Horie N, Fukuda Y, Izumo T, Hayashi K, Suyama K, Nagata I.

Acta Neurochir (Wien). 2014 May;156(5):919-26. doi: 10.1007/s00701-014-2054-4. Epub 2014 Mar 14.

PMID:
24627037
17.

Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.

Li Z, Zhou P, Xiong Z, Ma Z, Wang S, Bian H, Chen J.

Cerebrovasc Dis. 2013;35(5):455-60. doi: 10.1159/000350197. Epub 2013 May 31.

PMID:
23735877
18.

Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.

Rashad S, Fujimura M, Niizuma K, Endo H, Tominaga T.

Neurosurg Rev. 2016 Oct;39(4):615-23. doi: 10.1007/s10143-016-0734-7. Epub 2016 May 16.

PMID:
27180559
19.

Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.

Fujimura M, Shimizu H, Mugikura S, Tominaga T.

Surg Neurol. 2009 Feb;71(2):223-7; discussion 227. doi: 10.1016/j.surneu.2007.07.077. Epub 2008 Mar 4.

PMID:
18291489
20.

Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.

Nakagawa A, Fujimura M, Arafune T, Sakuma I, Tominaga T.

J Neurosurg. 2009 Dec;111(6):1158-64. doi: 10.3171/2009.4.JNS08585.

PMID:
19425891

Supplemental Content

Support Center